| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.36 |
Evidence |
|
| HMGN1 |
HMGN1, HMG14: Non-histone chromosomal protein HMG-14 |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
0.36 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
0.36 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
0.36 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
0.36 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
ICAM2 |
ICAM2: Intercellular adhesion molecule 2 precursor |
0.36 |
Evidence |
O
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD69 |
CD69: Early activation antigen CD69 |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
ADAM17 |
ADAM17, CSVP, TACE: ADAM 17 precursor |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD58 |
CD58, LFA3: Lymphocyte function-associated antigen 3 precursor |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD7 |
CD7: T-cell antigen CD7 precursor |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
0.36 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
CD2 |
CD2, SRBC: T-cell surface antigen CD2 precursor |
0.36 |
Evidence |
|
| VWF |
VWF, F8VWF: von Willebrand factor precursor |
NOTCH3 |
NOTCH3: Neurogenic locus notch homolog protein 3 precursor |
0.36 |
Evidence |
|
| THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
PTPRZ1 |
IPI00291099 |
0.36 |
Evidence |
|
| THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.36 |
Evidence |
|
| THY1 |
THY1: Thy-1 membrane glycoprotein precursor |
FGF9 |
FGF9: Glia-activating factor precursor |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
BAZ2A |
BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
JMJD1A |
JMJD1A, JHDM2A, JMJD1, KIAA0742: JmjC domain-containing histone demethylation pr |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
BAZ1B |
BAZ1B, WBSC10, WBSCR10, WBSCR9, WSTF: Bromodomain adjacent to zinc finger domain |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
TGIF2 |
TGIF2: Homeobox protein TGIF2 |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
PHF10 |
IPI00107282 |
0.36 |
Evidence |
|
| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
0.36 |
Evidence |
|